Back to Events
Important Notice: While we strive for accuracy, event details may be change or may be not accurate. We recommend contacting the official event organizer to verify dates and locations before making any arrangements.

WORLD DRUG SAFETY CONGRESS AMERICAS 2026

Location & Dates
City Boston, MA (USA)
Country USA
Start Date 14 Oct 2026
End Date 15 Oct 2026
Additional Information
Visitor Type Trade Public
Duration once a year
Year 2026

Want exhibitor list of WORLD DRUG SAFETY CONGRESS AMERICAS 2026? Contact us

Event Description

World Drug Safety Congress Americas 2026: Pioneering Safer Therapeutics in Boston
October 14–15, 2026 | Boston, MA, USA

The World Drug Safety Congress Americas 2026 returns to Boston, MA, as the premier gathering for pharmacovigilance, drug safety, and regulatory affairs professionals. Hosted at a state-of-the-art venue in the heart of America’s biotech hub, this two-day congress unites 500+ global experts—including regulators, pharmaceutical leaders, clinicians, and patient advocates—to address critical challenges and innovations in drug safety.

Key Themes & Content Highlights
Congress 2026 will delve into cutting-edge strategies to enhance drug safety across the product lifecycle:
- AI & Digital Transformation: Explore AI-driven pharmacovigilance, real-world data analytics, and blockchain for adverse event reporting.
- Regulatory Evolution: Navigate FDA/EMA updates on Risk Evaluation and Mitigation Strategies (REMS), pharmacovigilance system upgrades, and decentralized clinical trials.
- Oncology & Rare Diseases: Address safety complexities in novel therapies like CAR-T and gene editing, with focus on long-term monitoring.
- Patient-Centric Safety: Integrate patient-reported outcomes (PROs) and digital biomarkers into safety frameworks.
- Supply Chain Security: Combat counterfeit drugs and ensure integrity in global distribution networks.

Format & Learning Opportunities
Attendees will engage through:
- Keynote Presentations: Visionary talks from FDA leadership, global pharma CEOs, and patient safety pioneers.
- Interactive Workshops: Hands-on sessions on signal detection, safety database management, and AI tool implementation.
- Panel Debates: Multistakeholder discussions on post-marketing surveillance, pharmacovigilance 4.0, and global harmonization.
- Case Studies: Real-world lessons from drug recalls, safety label updates, and crisis management.

Why Attend?
- Networking: Connect with 200+ organizations, including top 20 pharma companies and regulatory bodies.
- Innovation Showcase: Explore tech solutions in the exhibition hall featuring AI platforms, safety software, and data analytics vendors.
- Career Growth: Access exclusive training on regulatory compliance, risk management, and leadership skills.
- Policy Influence: Shape the future of drug safety through collaborative roundtables with regulators and industry peers.

Boston: The Ideal Setting
As a global epicenter for biotech and medical research, Boston offers unparalleled access to leading institutions like MIT, Harvard, and the FDA’s New England District. The city’s vibrant ecosystem fosters collaboration, making it the perfect backdrop for advancing drug safety initiatives.

Join us to accelerate safer therapies, mitigate risks, and drive the next era of pharmacovigilance. Secure your place at the forefront of drug safety innovation—register now at [www.drugsafetycongressamericas.com](https://www.drugsafetycongressamericas.com).

Early bird registration opens May 2026. Limited sponsorships available.